Detalles de la búsqueda
1.
Effects of Alcohol Cue Reactivity on Subsequent Treatment Outcomes Among Treatment-Seeking Individuals with Alcohol Use Disorder: A Multisite Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Varenicline.
Alcohol Clin Exp Res
; 44(7): 1431-1443, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32363592
2.
Medication Development for Alcohol Use Disorder: A Focus on Clinical Studies.
Handb Exp Pharmacol
; 258: 443-462, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31628604
3.
Maintenance of World Health Organization Risk Drinking Level Reductions and Posttreatment Functioning Following a Large Alcohol Use Disorder Clinical Trial.
Alcohol Clin Exp Res
; 43(5): 979-987, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30951210
4.
Gabapentin Enacarbil Extended-Release for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multisite Trial Assessing Efficacy and Safety.
Alcohol Clin Exp Res
; 43(1): 158-169, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30403402
5.
Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder.
Alcohol Clin Exp Res
; 42(12): 2453-2465, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30395350
6.
Advances in Pharmacotherapy Development: Human Clinical Studies.
Handb Exp Pharmacol
; 248: 579-613, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29294197
7.
Posttreatment Low-Risk Drinking as a Predictor of Future Drinking and Problem Outcomes Among Individuals with Alcohol Use Disorders: A 9-Year Follow-Up.
Alcohol Clin Exp Res
; 41(3): 653-658, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28072453
8.
Clinical Validation of Reduced Alcohol Consumption After Treatment for Alcohol Dependence Using the World Health Organization Risk Drinking Levels.
Alcohol Clin Exp Res
; 41(1): 179-186, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28019652
9.
Temporal Stability of Heavy Drinking Days and Drinking Reductions Among Heavy Drinkers in the COMBINE Study.
Alcohol Clin Exp Res
; 41(5): 1054-1062, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28295414
10.
Discovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications Development.
Alcohol Clin Exp Res
; 40(7): 1368-79, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27184259
11.
Missing Data in Alcohol Clinical Trials with Binary Outcomes.
Alcohol Clin Exp Res
; 40(7): 1548-57, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27254113
12.
Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
Subst Abus
; 37(2): 286-98, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26928397
13.
Five Priority Areas for Improving Medications Development for Alcohol Use Disorder and Promoting Their Routine Use in Clinical Practice.
Alcohol Clin Exp Res
; 44(1): 23-35, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31803968
14.
Alcohol medications development: advantages and caveats of government/academia collaborating with the pharmaceutical industry.
Alcohol Clin Exp Res
; 38(5): 1196-9, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24689461
15.
Research opportunities for medications to treat alcohol dependence: addressing stakeholders' needs.
Alcohol Clin Exp Res
; 38(1): 27-32, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23889161
16.
Methods to analyze treatment effects in the presence of missing data for a continuous heavy drinking outcome measure when participants drop out from treatment in alcohol clinical trials.
Alcohol Clin Exp Res
; 38(11): 2826-34, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25421518
17.
Five-year healthcare utilization and costs among lower-risk drinkers following alcohol treatment.
Alcohol Clin Exp Res
; 38(2): 579-86, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24117604
18.
Assessing the drinking status of liver transplant patients with alcoholic liver disease.
Liver Transpl
; 19(4): 369-76, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23281299
19.
Posttreatment low-risk drinking as a predictor of future drinking and problem outcomes among individuals with alcohol use disorders.
Alcohol Clin Exp Res
; 37 Suppl 1: E373-80, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22827502
20.
The placebo effect in clinical trials for alcohol dependence: an exploratory analysis of 51 naltrexone and acamprosate studies.
Alcohol Clin Exp Res
; 37(12): 2128-37, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23889231